Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis

Thyroid

Volumn 8, Issue 3, 1998, Pages 235-239

  Hidaka, Yoh ^a   Okumura, Motoshi ^a   Shimaoka, Yuki ^a   Takeoka, Keiko ^a   Tada, Hisato ^a   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FREE THYROXINE INDEX; GRAVES DISEASE; HASHIMOTO DISEASE; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0031891993     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.235     Document Type: Article

References (19)

1. Mosmann TR, Sad S 1996 The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
2. Lazarus JH 1997 Hyperthyroidism. Lancet 349:339-343.
3. Hidaka Y, Amino N, Iwatani Y, Itoh E, Matsunaga M, Tamaki H 1993 Recurrence of thyrotoxicosis after attack of allergic rhinitis in patients with Graves' disease. J Clin Endocrinol Metab 77:1667-1670.
4. Hidaka Y, Masai T, Sumizaki H, Takeoka K, Tada H, Amino N 1996 Onset of Graves' thyrotoxicosis after an attack of allergic rhinitis. Thyroid 6:347-351.
5. Romagnani S 1997 The Th1/Th2 paradigm. Immunol Today 18:263-266.
6. Corrigan CJ, Haczku A, Gemou EV, Doi S, Kikuchi Y, Takatsu K, Durham SR, Kay AB 1993 CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 147:540-547.
7. Okumura M, Hidaka Y, Kuroda S, Takeoka K, Tada H, Amino N 1997 Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 82:1757-1760.
8. Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K 1987 Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. J Clin Endocrinol Metab 65:324-330.
9. Sanderson CJ 1992 Interleukin-5, eosinophils, and disease. Blood 79:3101-3109.
10. Bagley CJ, Lopez AF, Vadas MA 1997 New frontiers for IL-5. J Allergy Clin Immunol 99:725-728.
11. Sanderson CJ, Campbell HD, Young IG 1988 Molecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells. Immunol Rev 102:29-50.
12. Takatsu K, Tominaga A, Harada N, Mita S, Matsumoto M, Takahashi T, Kikuchi Y, Yamaguchi N 1988 T cell-replacing factor (TRF)/interleukin 5 (IL-5): Molecular and functional properties. Immunol Rev 102:107-135.
13. Tominaga A, Takaki S, Koyama N, Katoh S, Matsumoto R, Migita M, Hitoshi Y, Hosoya Y, Yamauchi S, Kanasi Y, Miyazaki J, Usuku G, Yamamura K, Takatsu K 1991 Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J Exp Med 173:429-437.
14. Salvi M, Girasole G, Pedrazzoni M, Passed M, Giuliani N, Minelli R, Braverman LE, Roti E 1996 Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 81:2976-2979.
15. Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I, Tarjan G, Stern PH 1997 Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab 82:78-81.
16. Celik I, Akalin S, Erbas T 1995 Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment. Eur J Endocrinol 132:668-672.
17. Mullins RJ, Cohen SB, Webb LM, Chernajovsky Y, Dayan CM, Londei M, Feldmann M 1995 Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines. J Clin Invest 96:30-37.
18. Heuer M, Aust G, Ode-hakim S, Scherbaum WA 1996 Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 6:97-106.
19. Iwatani Y, Amino N, Kaneda T, Ichihara K, Tamaki H, Tachi J, Matsuzuka F, Fukata S, Kuma K, Miyai K 1989 Marked increase of CD5+ B cells in hyperthyroid Graves' disease. Clin Exp Immunol 78:196-200.